< 回列表
Eiji Oki
- Professor, Department of Advanced Medicine and Innovative Technology, Kyushu University , Japan
Refining the Role of Neoadjuvant Therapy in Gastrointestinal Cancers: Integration of ctDNA and Whole-Genome MRD Approaches
| 角色 | 講師 |
| 日期時間 | 05/02 13:40 - 14:20 |
| 地點 | 701A |
學歷 / 訓練
1993, M.D., Kyushu University, Faculty of Medicine
1999, PhD., Kyushu University, Graduate School
專業與研究經歷
1993, Dana-Farber Cancer Institure, Harbard Medical School
重要出版品
- Nakamura Y, Watanabe J, Akazawa N, Hirata K, Kataoka K, Yokota M, Kato K, Kotaka M, Kagawa Y, Yeh KH, Mishima S, Yukami H, Ando K, Miyo M, Misumi T, Yamazaki K, Ebi H, Okita K, Hamabe A, Sokuoka H, Kobayashi S, Laliotis G, Aushev VN, Sharma S, Jurdi A, Liu MC, Aleshin A, Rabinowitz M, Bando H, Taniguchi H, Takemasa I, Kato T, Kotani D, Mori M, Yoshino T, Oki E: ctDNA-based molecular residual disease and survival in resectable colorectal cancer. Nat Med 2024, 30(11):3272-3283.
- Oki E, Nakanishi R, Ando K, Takemasa I, Watanabe J, Matsuhashi N, Kato T, Kagawa Y, Kotaka M, Hirata K, Sugiyama M, Kusumoto T, Miyamoto Y, Toyosaki K, Kishimoto J, Kimura Y, Yoshizumi T, Nakamura Y: Recurrence monitoring using ctDNA in patients with metastatic colorectal cancer: COSMOS-CRC-03 and AURORA studies. ESMO Gastrointest Oncol 2024, 3:100034.
- Kataoka K, Mori K, Nakamura Y, Watanabe J, Akazawa N, Hirata K, Yokota M, Kato K, Kotaka M, Yamazaki K, Kagawa Y, Mishima S, Ando K, Miyo M, Yukami H, Laliotis G, Sharma S, Palsuledesai CC, Rabinowitz M, Jurdi A, Liu MC, Aleshin A, Kotani D, Bando H, Taniguchi H, Takemasa I, Kato T, Yoshino T, Oki E: Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY. Ann Oncol 2024, 35(11):1015-1025.
- Kotani D, Oki E, Nakamura Y, Yukami H, Mishima S, Bando H, Shirasu H, Yamazaki K, Watanabe J, Kotaka M, Hirata K, Akazawa N, Kataoka K, Sharma S, Aushev VN, Aleshin A, Misumi T, Taniguchi H, Takemasa I, Kato T, Mori M, Yoshino T: Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer. Nat Med 2023, 29(1):127-134.
- Oki E, Watanabe J, Sato T, Kagawa Y, Kuboki Y, Ikeda M, Ueno H, Kato T, Kusumoto T, Masuishi T, Yamaguchi K, Kanazawa A, Nishina T, Uetake H, Yamanaka T, Yoshino T: Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI study. ESMO Open 2021, 6(3):100146.